All Insights
Showing 1 - 12 of 236
Artificial intelligence
New EU AI Act is poised to shape the future for life sciences in Europe
What is the extent of the sector's application of AI and the regulatory outlook following European Parliament approval?
Regulatory and compliance
European Parliament formally adopts Product Liability Directive
What changes and practical actions should businesses be considering?
International expansion and growth
Setting sail globally: launching internationally in an interconnected world
Launching a business internationally can be a game-changer but comes with its own set of challenges and considerations
Regulatory and compliance
UK government unveils draft procurement regulations for public sector bids
Authorities and suppliers will need to keep an eye on information published about procurements and resulting contracts
Life Sciences and Healthcare
Decision time for UK medical device regulation: diverge or converge with the EU?
The MHRA appears to be considering an approach for UK regulations that would broadly mirror the EU model
Life Sciences and Healthcare
Medication advertising in the digital age
The Generalitat of Catalonia has updated its guide to advertising medicines for human use with a focus on digital advertising
Intellectual property
What qualifies as a legitimate reason to object to parallel trade of medicines in Europe?
Trade mark owners are able to object to the parallel trade of medicines provided that there are legitimate reasons
Intellectual property
What are the patentability implications of deregulating gene editing in plants in the EU?
The European Parliament has voted to embrace more flexibility in the regulation of gene-edited plants but has proposed a ban
Life Sciences and Healthcare
Navigating Belgium's life sciences terrain: a strategic overview
Insights into regulations, trends, and strategic pathways for the pharmaceutical, medical device and food (supplement) industries
Life Sciences and Healthcare
EU assesses competition picture of the pharma sector
Commission reports to the Council on how EU antitrust and merger rules in the pharmaceutical sector have been enforced in
Regulatory and compliance
The UK Procurement Act 2023 brings new rules for frameworks and dynamic markets
The changes that are set to be introduced later this year could prove useful for both suppliers and authorities
Intellectual property
Updated EPO examination guidelines address AI, accelerated oppositions and antibody claims
The European Patent Office's new guidelines entered into force on 1 March
